AMR Stock Recent News

Alpha Metallurgical Resources, Inc. (NYSE:AMR ) Q1 2025 Earnings Conference Call May 9, 2025 10:00 AM ET Company Participants Emily O'Quinn - SVP-IR and Communications Andy Eidson - CEO Jason Whitehead - President and COO Todd Munsey - CFO Dan Horn - Chief Commercial Officer Conference Call Participants Nick Giles - B. Riley Securities Nathan Martin - The Benchmark Company Operator Greetings, and welcome to the Alpha Metallurgical Resources First Quarter 2025 Results Conference Call.

Alpha Metallurgical (AMR) came out with a quarterly loss of $2.60 per share versus the Zacks Consensus Estimate of a loss of $1.53. This compares to earnings of $9.59 per share a year ago.

Reports first quarter net loss of $33.9 million Posts Adjusted EBITDA of $5.7 million for the quarter Increases size of ABL from $155 million to $225 million through amended and extended agreement with new expiration of May 2029 Reduces metallurgical coal sales volume guidance range to 13.8 million to 14.8 million tons for the year; adjusts down range of thermal coal shipment expectations to 0.8 million to 1.2 million tons Lowers 2025 capex guidance range to $130 million to $150 million BRISTOL, Tenn., May 9, 2025 /PRNewswire/ -- Alpha Metallurgical Resources, Inc. (NYSE: AMR), a leading U.S. supplier of metallurgical products for the steel industry, today reported financial results for the first quarter ending March 31, 2025.

Alpha Metallurgical (AMR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

BOWLING GREEN, Ky.--(BUSINESS WIRE)--Holley Performance Brands (NYSE: HLLY), a leader in automotive aftermarket performance solutions, today announced a strategic collaboration with IndyCar for the 2025 race season. The company will outfit all 30 members of the AMR INDYCAR Safety Team—including physicians, paramedics, firefighters, EMTs and nurses—with top-rated Simpson fire suits to ensure the highest standards of protection. As part of this initiative, there will also be safety training throu.

AMR, APPF and EGBN have been added to the Zacks Rank #5 (Strong Sell) List on April 1, 2025.

CAMBRIDGE, Mass., March 11, 2025 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) – announced the initiation of dosing in the global clinical study, TRANSCEND. The Phase 3 study will evaluate the efficacy and safety of the investigational drug felzartamab compared to placebo in adult kidney transplant recipients diagnosed with late antibody-mediated rejection (AMR). TRANSCEND is designed to enroll approximately 120 kidney transplant recipients with late AMR.

Alpha Metallurgical Resources benefits from strong demand for met coal in developing markets like India, which supports long-term revenue growth despite global renewable energy trends. AMR's higher average selling prices and significant share buybacks position it as a more attractive investment compared to peers like BTU and HCC. Despite short-term price fluctuations and long-term renewable energy risks, AMR's robust financials and market position offer a 38.8% upside potential.

Alpha Metallurgical Resources, Inc. is the largest U.S. metallurgical coal miner, facing weak coking coal prices but still generating positive free cash flow. Q4 2024 results showed an $8M EBITDA increase and a minor $2M net loss, with stable sales volumes and slight price declines. AMR is well-capitalized, with $482M in cash and $519M in liquidity.

Alpha Metallurgical Resources, Inc. (NYSE:AMR ) Q4 2024 Earnings Conference Call February 28, 2025 10:00 AM ET Company Participants Emily O'Quinn - SVP-IR and Communications Andy Eidson - CEO Jason Whitehead - President and COO Todd Munsey - CFO Dan Horn - Chief Commercial Officer Conference Call Participants Nathan Martin - The Benchmark Company Nick Giles - B. Riley Operator Greetings, and welcome to the Alpha Metallurgical Resources Fourth Quarter 2024 Results Conference Call.